Agreement expands offering to include additional sheet, particulate and flowable productsMARIETTA, Ga., Feb. 04, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) ...
Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...
Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the launch of Cultrex™ Synthetic Hydrogel,a fully defined synthetic ...
The global amniotic products market is projected to grow at a CAGR of approximately 8%, reaching nearly USD 1 billion by 2031 ...
Gastric and esophageal cancers rank among the deadliest cancers Worldwide, due to their biological complexity, late diagnosis, and limited response to ...
As organisms develop from embryos, groups of cells migrate and reshape themselves to form all manner of complex tissues.
Pluri, Inc. ("Pluri", the "Company", "we" or "us") (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based solutions ...
Pluri, Inc. ('Pluri”, the 'Company”, 'we” or 'us”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ...
Osaka, Japan - Scientists at The University of Osaka have developed a novel hydrogel that enables the efficient, three-dimensional (3D) culture of human induced pluripotent stem cells (iPSCs). By ...
Department of Clinical and Biological Sciences and Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Torino, Orbassano, Italy The extracellular matrix (ECM) is a non-cellular and ...
1 The First Affiliated Hospital of Hunan Medical University, Changsha, China. 2 The Second Department of Radiotherapy, The Fifth People’s Hospital of Qinghai Province, Xining, China. 3 Department of ...